JANICE MEYER: Open Payments
NPI 1235250333 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 79 payments from 18 companies in 2025. Trend: 2023 $327 · 2024 $818 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $248 |
| ABBVIE INC. | 12 | $235 |
| Lilly USA, LLC | 9 | $151 |
| Novo Nordisk Inc | 10 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $116 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
| Exact Sciences Corporation | 3 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Abbott Laboratories | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
Products named: ELIQUIS, VRAYLAR, XIFAXAN, NURTEC ODT, UBRELVY, MOUNJARO, Wegovy, TZIELD.
Industry payments across MO — which companies pay providers there.
